Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-articular and Intravenous Infliximab in the Treatment of Resistant Seronegative Oligoarthritis of the Knee

NCT01216631 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT01216631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01216631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-articular and Intravenous Infliximab in the Treatment of Resistant Seronegative Oligoarthritis of the Knee
Lead sponsor
University of Leeds
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2010
Completion date
August 31, 2011
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spondylarthropathies